Adjuvant Anti-PD-1 Immunotherapy versus Conventional Therapy for Stage III Melanoma: A Real-World Retrospective Cohort Study

• Main Authors: Tong Li (Author), Yu Xu (Author), Wei Sun (Author), Wangjun Yan (Author), Chunmeng Wang (Author), Tu Hu (Author), Xiaowei Zhang (Author), Zhiguo Luo (Author), Xin Liu (Author), Yong Chen (Author)
• Format: Book
• Published: MDPI AG, 2022-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The use of adjuvant therapy has provided survival benefits in patients with advanced melanoma. This study aimed to explore the recurrence and prognosis of the PD-1 inhibitor, conventional interferon (IFN), or observation (OBS) on resected stage III acral and cutaneous melanoma patients through a ret...